4.7 Article

The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers

期刊

ACTA PHARMACEUTICA SINICA B
卷 12, 期 5, 页码 2479-2493

出版社

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2021.11.016

关键词

Long-circulating; In vivo fate; Aggregation-caused quenching; Nanoparticles; mPEG-PCL; Doxorubicin; Drug delivery; Pharmacokinetics

资金

  1. National Natural Science Foun-dation of China [81872815, 82030107, 81690263]
  2. Science and Technology Commission of Shanghai Municipality [19XD1400300]

向作者/读者索取更多资源

The study revisits the long-circulating effect of mPEG-PCL nanoparticles by monitoring the movement of drug payloads and nanocarriers. It demonstrates that pegylation can extend the circulation time of nanocarriers in the blood, although nanocarriers with dense PEG decoration are cleared quickly, and DOX is cleared faster than the nanocarriers. The study also shows that hepatic accumulation is the highest among all organs investigated but is inversely proportional to blood circulation time, suggesting possible leakage of DOX from the nanocarriers. Reduction in particle size and pegylation prove to be effective in extending circulation time and reducing uptake by organs of the mononuclear phagocytic system.
The long-circulating effect is revisited by simultaneous monitoring of the drug payloads and nanocarriers following intravenous administration of doxorubicin (DOX)-loaded methoxy polyethylene glycol-polycaprolactone (mPEG-PCL) nanoparticles. Comparison of the kinetic profiles of both DOX and nanocarriers verifies the long-circulating effect, though of limited degree, as a result of pegylation. The nanocarrier profiles display fast clearance from the blood despite dense PEG decoration; DOX is cleared faster than the nanocarriers. The nanocarriers circulate longer than DOX in the blood, suggesting possible leakage of DOX from the nanocarriers. Hepatic accumulation is the highest among all organs and tissues investigated, which however is reversely proportionate to blood circulation time. Pegylation and reduction in particle size prove to extend circulation of drug nanocarriers in the blood with simultaneous decrease in uptake by various organs of the mononuclear phagocytic system. It is concluded that the long-circulating effect of mPEG-PCL nanoparticles is reconfirmed by monitoring of either DOX or the nanocarriers, but the faster clearance of DOX suggests possible leakage of a fraction of the payloads. The findings of this study are of potential translational significance in design of nanocarriers towards optimization of both therapeutic and toxic effects. 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据